23Mar
Due to the COVID-19 pandemic, the Global Fund is canceling all missions until further notice. We will send an updated version of country missions as soon as we can via the usual communication channel.
06Mar
By: Jacki Evans, Ibon Villelabeitia and Ernest Waititu
Source: The Global Fund
In communities around the globe,
05Feb
Author: Kataisee RichardsonGlobal Fund-supported mechanisms in the region need to be better harmonized
Transition and sustainability are critical issues in Latin America and the Caribbean (LAC),
05Feb
Author: Ann Ithibu
43 countries expected to submit malaria funding requests in the first two application windows
A workshop to prepare countries that are eligible for Global Fund malaria funding in the 2020-2022 funding cycle,
05Feb
Author: Aidspan Staff
The Global Fund recently published on its website the 2020 Eligibility List of countries eligible to receive an allocation in the next funding cycle.
05Feb
Source: aidspan.org
Author: Samuel Muniu
Updated transitions list projects 12 countries becoming ‘upper-middle-income’ by 2028
According to the Global Fund to Fight AIDS,
05Feb
Source: aidspan.org
Author: Adèle Sulcas
Letters to each eligible country specify program split, co-financing commitments
Countries eligible for Global Fund funding in the 2020-2022 allocation period have been informed by the Global Fund Secretariat of their overall country allocations for this next funding cycle,
05Feb
Source: aidspan.org
Author: Adèle Sulcas
Overall amount increased by 23% compared to 2017-2019 allocations
05Dec
Source: aidspan.org
Author: Christelle Boulanger and Atiqa Chajai
A reflection on the need to review the CCM model and better adapt it to a country’s reality and objectives
When the Global Fund was born…
05Dec
Source: theglobalfund.org
HYDERABAD, India – A landmark agreement announced today by Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria and global biopharmaceutical company Sanofi will significantly lower the price of rifapentine,
